Search Results - "Tsianos, E"

The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO‐EpiCom Study of 209 pregnant women by Pedersen, N., Bortoli, A., Duricova, D., D′Inca, R., Panelli, M. R., Gisbert, J. P., Zoli, G., López‐Sanromán, A., Castiglione, F., Riegler, G., Annese, V., Gionchetti, P., Prada, A., Pont, E. D., Timmer, A., Felley, C., Shuhaibar, M., Tsianos, E. V., Dejaco, C., Baert, F. J., Jess, T., Lebech, M., Hommes, D. W., Munkholm, P.

“…Summary Background The impact of pregnancy on the course of IBD is still controversial. Aim To investigate the impact of pregnancy on IBD and to search for…”
Get full text

East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort by Burisch, J, Pedersen, N, Čuković-Čavka, S, Brinar, M, Kaimakliotis, I, Duricova, D, Shonová, O, Vind, I, Avnstrøm, S, Thorsgaard, N, Andersen, V, Krabbe, S, Dahlerup, J F, Salupere, R, Nielsen, K R, Olsen, J, Manninen, P, Collin, P, Tsianos, E V, Katsanos, K H, Ladefoged, K, Lakatos, L, Björnsson, E, Ragnarsson, G, Bailey, Y, Odes, S, Schwartz, D, Martinato, M, Lupinacci, G, Milla, M, De Padova, A, D'Incà, R, Beltrami, M, Kupcinskas, L, Kiudelis, G, Turcan, S, Tighineanu, O, Mihu, I, Magro, F, Barros, L F, Goldis, A, Lazar, D, Belousova, E, Nikulina, I, Hernandez, V, Martinez-Ares, D, Almer, S, Zhulina, Y, Halfvarson, J, Arebi, N, Sebastian, S, Lakatos, P L, Langholz, E, Munkholm, P

“…The incidence of inflammatory bowel disease (IBD) is increasing in Eastern Europe. The reasons for these changes remain unknown. The aim of this study was to…”
Get more information

The efficacy of shortening the dosing interval to once every six weeks in Crohn’s patients losing response to maintenance dose of infliximab by Kopylov, U., Mantzaris, G. J., Katsanos, K. H., Reenaers, C., Ellul, P., Rahier, J. F., Israeli, E., Lakatos, P. L., Fiorino, G., Cesarini, M., Tsianos, E. V., Louis, E., Ben‐Horin, S.

“…Aliment Pharmacol Ther 2011; 33: 349–357 Summary Background  Patients treated with infliximab for Crohn’s disease (CD) frequently require intensified dosage…”
Get full text

Cerebral sinus venous thrombosis in inflammatory bowel diseases by Katsanos, A H, Katsanos, K H, Kosmidou, M, Giannopoulos, S, Kyritsis, A P, Tsianos, E V

“…It has been estimated that 1.3-6.4% of patients with inflammatory bowel diseases (IBD) are complicated by cerebral venous thrombosis (CVT) at some point of…”
Get full text

Phenotype at diagnosis predicts recurrence rates in Crohn’s disease by Wolters, F L, Russel, M G, Sijbrandij, J, Ambergen, T, Odes, S, Riis, L, Langholz, E, Politi, P, Qasim, A, Koutroubakis, I, Tsianos, E, Vermeire, S, Freitas, J, van Zeijl, G, Hoie, O, Bernklev, T, Beltrami, M, Rodriguez, D, Stockbrügger, R W, Moum, B

“…Background: In Crohn’s disease (CD), studies associating phenotype at diagnosis and subsequent disease activity are important for patient counselling and…”
Get full text

Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: Results of the 2011 ECCO-EpiCom inception cohort by Vegh, Z., Burisch, J., Pedersen, N., Kaimakliotis, I., Duricova, D., Bortlik, M., Avnstrøm, S., Vinding, K. Kofod, Olsen, J., Nielsen, K.R., Katsanos, K.H., Tsianos, E.V., Lakatos, L., Schwartz, D., Odes, S., Lupinacci, G., De Padova, A., Jonaitis, L., Kupcinskas, L., Turcan, S., Tighineanu, O., Mihu, I., Barros, L.F., Magro, F., Lazar, D., Goldis, A., Fernandez, A., Hernandez, V., Niewiadomski, O., Bell, S., Langholz, E., Munkholm, P., Lakatos, P.L.

“…The aim of the present study was to validate the IBD (inflammatory bowel diseases) incidence reported in the 2010 ECCO-EpiCom (European Crohn's and Colitis…”
Get full text

Midodrine and furosemide‐induced natriuresis in cirrhotics with ascites by Kalambokis, G., Tsianos, E. V.

Get full text

Systematic review: hepatic fibrosis – regression with therapy by ZOIS, C. D., BALTAYIANNIS, G. H., KARAYIANNIS, P., TSIANOS, E. V.

“…Summary Background  Hepatic fibrosis occurs in response to chronic liver injury, regardless of the cause. An impressive amount of knowledge concerning the…”
Get full text

Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort by Vegh, Z., Burisch, J., Pedersen, N, Kaimakliotis, I, Duricova, D., Bortlik, M., Vinding, K. Kofod, Avnstrøm, S, Olsen, J., Nielsen, K. R., Katsanos, K. H., Tsianos, E. V., Lakatos, L., Schwartz, D., Odes, S., D’Incà, R., Beltrami, M., Kiudelis, G., Kupcinskap, L., Jucov, A., Turcan, S., Barros, L. F., Magro, F., Lazar, D., Goldis, A., de Castro, L, Hernandez, V, Niewiadomski, O., Bell, S., Langholz, E., Munkholm, P., Lakatos, P. L.

“…Background and Aims: The ECCO-EpiCom study investigates the differences in the incidence and therapeutic management of inflammatory bowel diseases [IBD]…”
Get full text

Case series of transpancreatic septotomy as precutting technique for difficult bile duct cannulation by Kapetanos, D, Kokozidis, G, Christodoulou, D, Mistakidis, K, Dimakopoulos, K, Katodritou, E, Kitis, G, Tsianos, E V

“…Transpancreatic septotomy can be used instead of other precut techniques to facilitate bile duct cannulation after multiple failed attempts. Within the…”
Get more information

Crohn’s disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort by Wolters, F L, Russel, M G, Sijbrandij, J, Schouten, L J, Odes, S, Riis, L, Munkholm, P, Bodini, P, O’Morain, C, Mouzas, I A, Tsianos, E, Vermeire, S, Monteiro, E, Limonard, C, Vatn, M, Fornaciari, G, Pereira, S, Moum, B, Stockbrügger, R W

“…Background: No previous correlation between phenotype at diagnosis of Crohn’s disease (CD) and mortality has been performed. We assessed the predictive value…”
Get full text

Brucellosis and the Respiratory System by Pappas, Georgios, Bosilkovski, Mile, Akritidis, Nikolaos, Mastora, Maria, Krteva, Liliana, Tsianos, Epaminondas

“…Brucellosis is a zoonotic disease that remains endemic worldwide. Its clinical manifestations and focal complications are often troublesome in making a…”
Get full text

Fenofibrate in primary biliary cirrhosis: a pilot study by Liberopoulos, E N, Florentin, M, Elisaf, M S, Mikhailidis, D P, Tsianos, E

“…Most patients with primary biliary cirrhosis (PBC) are treated with ursodeoxycholic acid (UDCA); however, some do not respond fully. PBC is also associated…”
Get full text

164 CORRELATION OF PLATELET COUNT WITH ENDOTOXAEMIA IN CIRRHOTIC PATIENTS WITH THROMBOCYTOPENIA AND EFFECTS OF RIFAXIMIN by Kalambokis, G, Mouzaki, A, Rodi, M, Tsianos, E

Get full text

163 TERLIPRESSIN EFFECTS ON PULMONARY VASCULAR RESISTANCE IN CIRRHOTIC PATIENTS WITH AND WITHOUT ECHOCARDIOGRAPHIC EVIDENCE OF PULMONARY HYPERTENSION by Kalambokis, G, Pappas, K, Korantzopoulos, P, Tsianos, E

Get full text

Treatment and non-treatment related ocular manifestations in patients with chronic hepatitis B or C by Tsoumani, A, Theopistos, V, Katsanos, K, Asproudis, I, Tsianos, E V

“…Worldwide, 480-520 million people are chronically infected with hepatitis B or C virus. In addition to their effects in the liver, chronic hepatitis viral…”
Get more information

Multiple myeloma presenting with an acute bacterial infection by KALAMBOKIS, G. N., CHRISTOU, L., TSIANOS, E. V.

“…Summary Increased susceptibility to bacterial infections is a common manifestation of multiple myeloma (MM), arising mainly from a defect in humoral immunity…”
Get full text

Clinical and economic outcomes in a population‐based European cohort of 948 ulcerative colitis and Crohn’s disease patients by Markov analysis by ODES, S., VARDI, H., FRIGER, M., ESSER, D., WOLTERS, F., MOUM, B., WATERS, H., ELKJAER, M., BERNKLEV, T., TSIANOS, E., O’MORAIN, C., STOCKBRÜGGER, R., MUNKHOLM, P., LANGHOLZ, E.

“…Aliment Pharmacol Ther 31, 735–744 Summary Background  Forecasting clinical and economic outcomes in ulcerative colitis (UC) and Crohn’s disease (CD) patients…”
Get full text

Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role? by Ciancio, A., Andreone, P., Kaiser, S., Mangia, A., Milella, M., Solà, R., Pol, S., Tsianos, E., De Rosa, A., Camerini, R., McBeath, R., Rizzetto, M.

“…This study was conducted to determine whether the adding thymosin alpha‐1 to standard of care for re‐treatment of nonresponding hepatitis C infections can…”
Get full text

Quinolones for brucellosis: treating old diseases with new drugs by Pappas, G., Christou, L., Akritidis, N., Tsianos, E.V.

“…Although quinolones are theoretically interesting candidates for the treatment of brucellosis, the existing data concerning their efficacy are limited and…”
Get full text